When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 20 Hits
  • Search Condition : Filter (MeSH = Breast Neoplasms / drug therapy*)
Species Resource
DNA material c-erbB2 promoter(533)-pGL2-basic (RDB02839) , pGL4-phESR1 (RDB07528). In vitro and in vivo effects of xanthorrhizol on human breast cancer MCF-7 cells treated with tamoxifen.
Silkworms Niemann-Pick disease type C2 protein induces autophagy and inhibits growth in FM3A breast cancer cells.
DNA material c-erbB2 promoter(533)-pGL2-basic (RDB02839) , c-erbB2 promoter(344)-pGL2-basic (RDB02840) , c-erbB2 promoter(251)-pGL2-basic (RDB02841) , c-erbB2 promoter(124)-pGL2-basic (RDB02842) , c-erbB2 promoter(251)-TK (RDB02843). A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
Human and Animal Cells MCF7(RCB1904) Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
Human and Animal Cells SAS(RCB1974) Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.
Human and Animal Cells Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells.
Human and Animal Cells Combination of the mTOR inhibitor ridaforolimus and the anti-IGF1R monoclonal antibody dalotuzumab: preclinical characterization and phase I clinical trial.
Human and Animal Cells MCF7(RCB1904) Histamine H3 receptor antagonist OUP-186 attenuates the proliferation of cultured human breast cancer cell lines.
Human and Animal Cells MDA-MB-453(RCB1192) , MCF7(RCB1904) Multifunctional Cu2-xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453.
Human and Animal Cells MDA-MB-453(RCB1192) , MCF7(RCB1904) Transcriptional repression of HER2 by ANO1 Cl- channel inhibition in human breast cancer cells with resistance to trastuzumab.
Human and Animal Cells MCF7(RCB1904) The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
Human and Animal Cells p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors.
Human and Animal Cells ST2 (RCB0224) RAW 264 (RCB0535) Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.
Human and Animal Cells MDA-MB-453 alpha-Tocopheryloxybutyric acid enhances necrotic cell death in breast cancer cells treated with chemotherapy agent.
Human and Animal Cells MDA-MB-453 Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent.
Human and Animal Cells HEV Radiosensitivity of peripheral blood lymphocytes obtained from patients with cancers of the breast, head and neck or cervix as determined with a micronucleus assay.
Human and Animal Cells Electrophoretic characterization of ribosomal subunits and proteins in apoptosis: specific downregulation of S11 in staurosporine-treated human breast carcinoma cells.
Human and Animal Cells Methylprednisolone as antiemetic treatment in breast-cancer patients receiving cyclophosphamide, methotrexate, and 5-fluorouracil: a prospective, crossover, randomized blind study comparing two different dose schedules.
Human and Animal Cells Drug-induced apoptosis and p53, BCL-2 and BAX expression in breast cancer tissues in vivo and in fibroblast cells in vitro.
Human and Animal Cells HL-60(RCB3683) Optimizing the dosing schedule of l-asparaginase improves its anti-tumor activity in breast tumor-bearing mice.